|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3766 USD | +2.34% |
|
+4.61% | -43.30% |
BioCardia, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 0.477 million compared to USD 1.35 million a year ago. Net loss was USD 11.57 million compared to USD 11.91 million a year ago.
Basic loss per share from continuing operations was USD 0.55 compared to USD 0.67 a year ago. Diluted loss per share from continuing operations was USD 0.55 compared to USD 0.67 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -43.30% | 10.12M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
BIOCARDIA, INC. 
